CARsgen Therapeutics

CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that…